Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin

G. Paganelli, M. Stella, F. Zito, P. Magnani, P. De Nardi, F. Mangili, D. Baratti, F. Veglia, V. Di Carlo, A. G. Siccardi, F. Fazio

Research output: Contribution to journalArticlepeer-review


One of the limitations of intraoperative tumor detection with radiolabeled monoclonal antibody (Mab), by means of a gamma-detecting probe (GDP), is the long time interval needed between Mab injection and surgery to obtain low blood-pool activity. Such an interval can be shortened considerably, exploiting the high affinity between avidin and biotin. Methods: Twenty patients with colorectal cancer were injected with 1 mg of biotinylated 125I monoclonal antibodies followed, 48 hr later, by a chase of cold avidin. During surgery, the GDP was used to detect radioactive emissions from the tumor and normal tissue. Tumor tissue samples were analyzed in vitro by immunohistochemical tests for the presence of tumor antigens and in vivo antibody localization. Results: At the time of surgery (average 7 days postinjection), the mean value of circulating radioactivity was 6% ± 3% of the injected dose. Of 20 patients studied, tumors were localized in 13 cases (65%). Subclinical tumors were detected in 3 patients (15%). Conclusion: The use of 125I-labeled biotinylated Mabs followed by avidin as a chase enhances the applicability and effectiveness of radioimmunoguided surgery technology and will allow the use of radioisotopes with a shorter half-life than 125I.

Original languageEnglish
Pages (from-to)1970-1975
Number of pages6
JournalJournal of Nuclear Medicine
Issue number12
Publication statusPublished - 1994


  • avidin-biotin
  • monoclonal antibody
  • RIGS

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology


Dive into the research topics of 'Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin'. Together they form a unique fingerprint.

Cite this